Amedeo Smart

Free Medical Literature Service



Breast Cancer

  Free Subscription

Articles published in
Cancer Cell
    July 2021
  1. PEREZ-GARCIA J, Gion M, Cortes J
    I-SPY2 platform: New lessons from the olaparib and durvalumab combination in breast cancer treatment.
    Cancer Cell. 2021;39:902-904.
    >> Share

    June 2021
  2. PUSZTAI L, Yau C, Wolf DM, Han HS, et al
    Durvalumab with olaparib and paclitaxel for high-risk HER2-negative stage II/III breast cancer: Results from the adaptively randomized I-SPY2 trial.
    Cancer Cell. 2021 Jun 2. pii: S1535-6108(21)00275.
    >> Share

    March 2021
    Understanding divergent trial results of adjuvant CDK4/6 inhibitors for early stage breast cancer.
    Cancer Cell. 2021;39:307-309.
    >> Share

  4. LIANG H
    Size matters: toward reliable breast cancer risk assessment for every woman.
    Cancer Cell. 2021 Mar 8. pii: S1535-6108(21)00120.
    >> Share

    December 2020
  5. XIAO Y, Cong M, Li J, He D, et al
    Cathepsin C promotes breast cancer lung metastasis by modulating neutrophil infiltration and neutrophil extracellular trap formation.
    Cancer Cell. 2020 Dec 31. pii: S1535-6108(20)30660.
    >> Share

  6. BAGATI A, Kumar S, Jiang P, Pyrdol J, et al
    Integrin alphavbeta6-TGFbeta-SOX4 Pathway Drives Immune Evasion in Triple-Negative Breast Cancer.
    Cancer Cell. 2020 Dec 22. pii: S1535-6108(20)30608.
    >> Share

    October 2020
  7. CHANG G, Shi L, Ye Y, Shi H, et al
    YTHDF3 Induces the Translation of m(6)A-Enriched Gene Transcripts to Promote Breast Cancer Brain Metastasis.
    Cancer Cell. 2020 Oct 16. pii: S1535-6108(20)30498.
    >> Share

  8. HILLIS AL, Toker A
    Lactate Lights up PI3K Inhibitor Resistance in Breast Cancer.
    Cancer Cell. 2020;38:441-443.
    >> Share

    September 2020
  9. PUSZTAI L, Taylor R, Mougalian SS
    Text Messaging to Increase Compliance with Adjuvant Endocrine Therapy in Breast Cancer.
    Cancer Cell. 2020;38:323-325.
    >> Share

  10. ROS S, Wright AJ, D'Santos P, Hu DE, et al
    Metabolic Imaging Detects Resistance to PI3Kalpha Inhibition Mediated by Persistent FOXM1 Expression in ER(+) Breast Cancer.
    Cancer Cell. 2020 Sep 14. pii: S1535-6108(20)30427.
    >> Share

    August 2020
  11. ARRUABARRENA-ARISTORENA A, Maag JLV, Kittane S, Cai Y, et al
    FOXA1 Mutations Reveal Distinct Chromatin Profiles and Influence Therapeutic Response in Breast Cancer.
    Cancer Cell. 2020 Aug 25. pii: S1535-6108(20)30414.
    >> Share

    July 2020
  12. SIERSBAEK R, Scabia V, Nagarajan S, Chernukhin I, et al
    IL6/STAT3 Signaling Hijacks Estrogen Receptor alpha Enhancers to Drive Breast Cancer Metastasis.
    Cancer Cell. 2020 Jul 6. pii: S1535-6108(20)30311.
    >> Share

    June 2020
  13. GURUSAMY D, Henning AN, Yamamoto TN, Yu Z, et al
    Multi-phenotype CRISPR-Cas9 Screen Identifies p38 Kinase as a Target for Adoptive Immunotherapies.
    Cancer Cell. 2020;37:818-833.
    >> Share

    May 2020
  14. SAVAS P, Loi S
    Expanding the Role for Immunotherapy in Triple-Negative Breast Cancer.
    Cancer Cell. 2020;37:623-624.
    >> Share

    April 2020
  15. HANKER AB, Sudhan DR, Arteaga CL
    Overcoming Endocrine Resistance in Breast Cancer.
    Cancer Cell. 2020;37:496-513.
    >> Share

    February 2020
  16. ZHENG ZY, Anurag M, Lei JT, Cao J, et al
    Neurofibromin Is an Estrogen Receptor-alpha Transcriptional Co-repressor in Breast Cancer.
    Cancer Cell. 2020 Feb 25. pii: S1535-6108(20)30092.
    >> Share

  17. SUDHAN DR, Guerrero-Zotano A, Won H, Gonzalez Ericsson P, et al
    Hyperactivation of TORC1 Drives Resistance to the Pan-HER Tyrosine Kinase Inhibitor Neratinib in HER2-Mutant Cancers.
    Cancer Cell. 2020;37:183-199.
    >> Share

    November 2019
  18. HOPKINS JL, Zou L
    Induction of BRCAness in Triple-Negative Breast Cancer by a CDK12/13 Inhibitor Improves Chemotherapy.
    Cancer Cell. 2019;36:461-463.
    >> Share

    October 2019
  19. QUEREDA V, Bayle S, Vena F, Frydman SM, et al
    Therapeutic Targeting of CDK12/CDK13 in Triple-Negative Breast Cancer.
    Cancer Cell. 2019 Oct 8. pii: S1535-6108(19)30424.
    >> Share

    April 2019
  20. BRONTE V
    Deciphering Macrophage and Monocyte Code to Stratify Human Breast Cancer Patients.
    Cancer Cell. 2019;35:538-539.
    >> Share

    January 2019
  21. ISHAY-RONEN D, Diepenbruck M, Kalathur RKR, Sugiyama N, et al
    Gain Fat-Lose Metastasis: Converting Invasive Breast Cancer Cells into Adipocytes Inhibits Cancer Metastasis.
    Cancer Cell. 2019;35:17-32.
    >> Share

  22. HINZ S, LaBarge MA
    Hijacking EMT: Better Fat Than Dead.
    Cancer Cell. 2019;35:1-2.
    >> Share

    December 2018
  23. SHEN M, Jiang YZ, Wei Y, Ell B, et al
    Tinagl1 Suppresses Triple-Negative Breast Cancer Progression and Metastasis by Simultaneously Inhibiting Integrin/FAK and EGFR Signaling.
    Cancer Cell. 2018 Dec 10. pii: S1535-6108(18)30537.
    >> Share

    May 2018
  24. CANOVAS B, Igea A, Sartori AA, Gomis RR, et al
    Targeting p38alpha Increases DNA Damage, Chromosome Instability, and the Anti-tumoral Response to Taxanes in Breast Cancer Cells.
    Cancer Cell. 2018 May 14. pii: S1535-6108(18)30181.
    >> Share

    March 2018
  25. LI L, Liang Y, Kang L, Liu Y, et al
    Transcriptional Regulation of the Warburg Effect in Cancer by SIX1.
    Cancer Cell. 2018;33:368-385.
    >> Share

    February 2018
  26. LI CW, Lim SO, Chung EM, Kim YS, et al
    Eradication of Triple-Negative Breast Cancer Cells by Targeting Glycosylated PD-L1.
    Cancer Cell. 2018;33:187-201.
    >> Share

  27. SALATINO M, Girotti MR, Rabinovich GA
    Glycans Pave the Way for Immunotherapy in Triple-Negative Breast Cancer.
    Cancer Cell. 2018;33:155-157.
    >> Share

  28. MCDONNELL DP, Norris JD, Chang CY
    Neomorphic ERalpha Mutations Drive Progression in Breast Cancer and Present a Challenge for New Drug Discovery.
    Cancer Cell. 2018;33:153-155.
    >> Share

  29. COSTA A, Kieffer Y, Scholer-Dahirel A, Pelon F, et al
    Fibroblast Heterogeneity and Immunosuppressive Environment in Human Breast Cancer.
    Cancer Cell. 2018 Feb 12. pii: S1535-6108(18)30011.
    >> Share

  30. JESELSOHN R, Bergholz JS, Pun M, Cornwell M, et al
    Allele-Specific Chromatin Recruitment and Therapeutic Vulnerabilities of ESR1 Activating Mutations.
    Cancer Cell. 2018;33:173-186.
    >> Share

    January 2018
  31. DE MINGO PULIDO A, Gardner A, Hiebler S, Soliman H, et al
    TIM-3 Regulates CD103(+) Dendritic Cell Function and Response to Chemotherapy in Breast Cancer.
    Cancer Cell. 2018;33:60-74.
    >> Share

    November 2017
  32. PALAZON A, Tyrakis PA, Macias D, Velica P, et al
    An HIF-1alpha/VEGF-A Axis in Cytotoxic T Cells Regulates Tumor Progression.
    Cancer Cell. 2017;32:669-683.
    >> Share

    October 2017
  33. GULLUNI F, Martini M, De Santis MC, Campa CC, et al
    Mitotic Spindle Assembly and Genomic Stability in Breast Cancer Require PI3K-C2alpha Scaffolding Function.
    Cancer Cell. 2017;32:444-459.
    >> Share

  34. ROBERTS KJ, Kershner AM, Beachy PA
    The Stromal Niche for Epithelial Stem Cells: A Template for Regeneration and a Brake on Malignancy.
    Cancer Cell. 2017;32:404-410.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016